FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor ’s office or clinic

FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults with treatment-resistant depression
Source: Food and Drug Administration - Category: American Health Source Type: news